American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1965)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (5)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1362)

Results (4047)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax
    Journal Article

    Satta, T.; Li, L.; Chalasani, S. L.; Hu, X.; Nkwocha, J.; Sharma, K.; Kmieciak, M.; Rahmani, M.; Zhou, L.; Grant, S.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer
    Journal Article

    Jagadeeshan, S.; Prasad, M.; Badarni, M.; Ben-Lulu, T.; Liju, V. B.; Mathukkada, S.; Saunders, C.; Shnerb, A. B.; Zorea, J.; Yegodayev, K. M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Crizotinib has preclinical efficacy in Philadelphia-negative myeloproliferative neoplasms
    Journal Article

    Gurska, L. M.; Okabe, R.; Schurer, A.; Tong, M. M.; Soto, M.; Choi, D.; Ames, K.; Glushakow-Smith, S.; Montoya, A.; Tein, E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A single-arm phase II trial of sitravatinib in advanced well-differentiated/dedifferentiated liposarcoma
    Journal Article

    Ingham, M.; Lee, S.; Van Tine, B. A.; Choy, E.; Oza, J.; Doshi, S.; Ge, L.; Oppelt, P.; Cote, G.; Corgiat, B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer
    Journal Article

    Qiu, H.; Makarov, V.; Bolzenius, J. K.; Halstead, A.; Parker, Y.; Wang, A.; Iyer, G. V.; Wise, H.; Kim, D.; Thayaparan, V.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Dynamic mutational landscape of cerebrospinal fluid circulating tumor DNA and predictors of survival after proton craniospinal irradiation for leptomeningeal metastases
    Journal Article

    Wijetunga, N. A.; Goglia, A. G.; Weinhold, N.; Berger, M. F.; Cislo, M.; Higginson, D. S.; Chabot, K.; Osman, A. M.; Schaff, L.; Pentsova, E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Enhancing CD19 chimeric antigen receptor T cells through memory-enriched T cells
    Editorial

    El Marabti, E.; Abdel-Wahab, O.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Five-year clinical outcomes after neoadjuvant nivolumab in resectable non-small cell lung cancer
    Journal Article

    Rosner, S.; Reuss, J. E.; Zahurak, M.; Zhang, J.; Zeng, Z.; Taube, J.; Anagnostou, V.; Smith, K. N.; Riemer, J.; Illei, P. B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Pilot study of ONCOS-102 and pembrolizumab: Remodeling of the tumor microenvironment and clinical outcomes in anti-PD-1-resistant advanced melanoma
    Journal Article

    Shoushtari, A. N.; Olszanski, A. J.; Nyakas, M.; Hornyak, T. J.; Wolchok, J. D.; Levitsky, V.; Kuryk, L.; Hansen, T. B.; Jäderberg, M.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
    Journal Article

    Belhadj, S.; Khurram, A.; Bandlamudi, C.; Palou-Márquez, G.; Ravichandran, V.; Steinsnyder, Z.; Wildman, T.; Catchings, A.; Kemel, Y.; Mukherjee, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: